Catalyst Wire Dossier Catalyst Wire Dossier
EMA approval · 2025-06-24

EMA Authorised: Tolucombi (telmisartan;hydrochlorothiazide) — Krka, d.d., Novo mesto

View source ↗

Summary

The European Medicines Agency has authorized Tolucombi, a fixed-dose combination tablet of telmisartan and hydrochlorothiazide, for the treatment of hypertensio…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HYDROCHLOROTHIAZIDE (hydrochlorothiazide)
  • Telmisartan (Telmisartan)

Snippet

Status: Authorised. Therapeutic area: Hypertension. MAH: Krka, d.d., Novo mesto. Decision date: 19/06/2025